ASIACOMMERCE - Entering Indonesia with medical devices requires regulatory preparation long before the first commercial shipment leaves the manufacturer.

Foreign manufacturers must understand product classification, local representation, technical documentation, import requirements, distribution controls, and post-market responsibilities.

Indonesia regulates medical devices through the Ministry of Health, commonly known as Kemenkes RI.

The regulatory framework received an important update through Ministry of Health Regulation No. 5 of 2026 on Health Supplies.

This regulation governs broader requirements covering health supplies, including medical devices and their circulation.

A product cannot enter the Indonesian market simply because another country has already approved it.

Manufacturers must follow Indonesia's applicable registration and market-entry requirements before commercial distribution.

Imported medical devices generally require an Indonesian marketing authorization before they can circulate commercially.

Indonesia identifies imported medical device authorizations through the AKL pathway.

The regulatory process also follows a risk-based approach.

Higher-risk products generally require more extensive technical evidence and regulatory scrutiny.

Foreign manufacturers must therefore understand their device classification before preparing the registration dossier.

They must also decide who will represent the product legally and commercially in Indonesia.

These decisions affect registration, importation, distribution, and post-market responsibilities after launch.

Written by the AsiaCommerce Market Entry Team — B2B cross-border procurement and distribution specialists operating under PT Exim Jaya Abadi and PT Kalimas Mitra Perkasa since 2016. Last updated: September 2026.

Understand Indonesia's Medical Device Risk Classification

Indonesia classifies medical devices according to the level of risk associated with their intended use.

The framework aligns broadly with ASEAN medical device harmonization principles.

Indonesia uses four primary risk classes: A, B, C, and D.

Class A covers devices with relatively low risk.

Examples can include basic products where device failure creates limited harm for patients or users.

Class B covers devices with low to moderate risk.

These products require greater regulatory control than Class A devices because failure can create more significant consequences.

Class C covers devices with moderate to high risk.

This category can include more complex diagnostic, monitoring, or therapeutic equipment.

Class D represents the highest-risk category.

Life-supporting, implantable, or other critical medical devices can fall within this class.

Product classification directly affects the amount of regulatory evidence a manufacturer should prepare.

Higher-risk devices generally demand more extensive technical, safety, performance, and clinical documentation.

Manufacturers should therefore avoid choosing a class based only on similar-looking products.

The intended purpose, design, duration of contact, invasiveness, and technical characteristics can influence classification.

Incorrect classification can create delays during evaluation or require additional documentation.

Foreign manufacturers should establish the correct classification before finalizing their Indonesian registration strategy.

(ALSO READ: How to Source Products From China in 2026: A Complete Guide for Global Businesses)

This step also affects sourcing decisions when a company manufactures devices through an external facility.

A contract manufacturer must provide documentation that supports the final registration dossier.

AsiaCommerce approaches product classification as part of the broader market-entry workflow.

Our team connects supplier documentation, compliance preparation, import planning, and local distribution requirements.

This connection matters because regulatory documentation often starts at the manufacturing source.

A missing technical record can become an Indonesian market-entry problem months after production begins.

Foreign manufacturers should therefore build regulatory readiness into the supply chain from the beginning.

Foreign Manufacturers Need a Local Market Entry Structure

A foreign medical device manufacturer cannot treat Indonesia as a purely direct-to-customer export market.

The company needs an appropriate Indonesian business structure to support registration and distribution.

Foreign manufacturers commonly appoint a qualified local entity to represent their products.

This party can act as the authorized representative or appointed distributor within the applicable regulatory structure.

The relationship normally requires formal authorization from the overseas manufacturer.

A Letter of Authorization can establish the relationship between the manufacturer and its Indonesian representative.

This decision deserves careful commercial consideration.

The local party can become closely connected with the product's regulatory authorization and market access.

Manufacturers should therefore evaluate regulatory capability, distribution readiness, documentation management, and operational reliability before appointing a partner.

The local business also needs appropriate Indonesian business licensing.

Its activities must align with the relevant medical device business classifications and regulatory permissions.

Distribution requirements can include implementation of good distribution practices for medical devices.

Indonesia commonly refers to this framework as CDAKB, or Cara Distribusi Alat Kesehatan yang Baik.

The distribution operation should maintain suitable facilities for the products it handles.

Temperature-sensitive devices may require more specialized storage and monitoring.

Technical responsibility within the distribution organization also forms an important part of regulatory control.

Foreign manufacturers should view these requirements as more than paperwork.

Medical device quality can deteriorate through poor storage, handling, or distribution even after compliant manufacturing.

AsiaCommerce operates legally under PT Exim Jaya Abadi and PT Kalimas Mitra Perkasa in Indonesia.

Since 2016, our team has supported cross-border businesses through sourcing, market-entry coordination, warehousing, and distribution workflows.

This operating model helps foreign companies connect regulatory preparation with the infrastructure needed after approval.

Prepare the Registration Dossier Before Market Entry

Indonesia's medical device registration process requires both administrative and technical documentation.

Foreign manufacturers should prepare these materials before expecting a smooth submission process.

Indonesia uses documentation principles that reflect the ASEAN Common Submission Dossier Template framework.

Administrative documentation can include evidence concerning the overseas manufacturer and its Indonesian representative.

A Letter of Authorization typically supports the formal appointment of the local representative.

Manufacturers may also need a Free Sale Certificate from the relevant authority in the country of origin.

Quality-system documentation represents another important element.

ISO 13485 certification commonly supports evidence of a medical device manufacturer's quality management system.

However, certification alone does not replace product-specific technical documentation.

The dossier should explain what the product is and how it works.

Manufacturers should prepare product descriptions, intended use, components, specifications, materials, and relevant technical characteristics.

(ALSO READ: How to Import Cosmetics into Indonesia: BPOM Registration and Market Entry Guide)

Testing evidence must match the risks and technical features of the product.

Applicable documentation can include electrical safety, performance, biocompatibility, or other relevant test reports.

Higher-risk devices can require stronger clinical evidence.

Class C and Class D products can therefore require more extensive evaluation than lower-risk devices.

Labeling and Instructions for Use also form part of market-entry preparation.

Manufacturers should prepare Indonesia-specific versions rather than treating packaging as a final marketing task.

The electronic registration process connects regulatory submissions with Indonesia's broader business licensing environment.

Approved imported devices receive an imported medical device marketing authorization associated with the AKL designation.

Foreign companies should not wait until registration starts before requesting documents from their factories.

Manufacturers and suppliers can take time to produce certificates, reports, technical files, and supporting evidence.

This issue becomes even more important for companies sourcing medical devices from China.

AsiaCommerce can support China supplier verification, factory audits, negotiation, and quality control before market-entry execution.

Connecting sourcing and registration reduces the risk of selecting a factory that cannot support the destination country's documentation requirements.

Registration Is Only One Part of Import and Distribution

A marketing authorization does not automatically solve every operational requirement for importing medical devices into Indonesia.

The authorized business still needs to comply with applicable import and customs procedures.

Indonesia's current health-supplies framework connects marketing authorization data with import controls.

Import documentation can function within border or post-border regulatory checks depending on the applicable mechanism.

Businesses should confirm shipment requirements before dispatching commercial inventory.

This approach reduces the risk of discovering document gaps after goods reach Indonesia.

Labeling also requires careful preparation.

Medical devices must provide required safety, benefit, and usage information clearly and accurately.

Applicable information can include the product name, manufacturer, responsible local party, authorization information, lot details, and storage instructions.

Instructions for Use may also require Bahasa Indonesia according to applicable product requirements.

Manufacturers should confirm the exact labeling obligations for their device classification and intended use.

Traceability becomes increasingly important for higher-risk and more complex devices.

Businesses should maintain records that connect imported products with distribution and post-market activities.

Regulatory responsibility also continues after commercial launch.

Indonesia's 2026 framework provides for monitoring during circulation and use.

Marketing authorization holders can face vigilance obligations related to device safety and performance.

They must respond appropriately when market information identifies safety or quality problems.

The regulatory framework also provides mechanisms for product withdrawal when products fail applicable safety, quality, or labeling requirements.

Manufacturers should therefore establish complaint handling, investigation, corrective action, and recall procedures before commercial launch.

Post-market compliance should not begin only after the first serious complaint occurs.

Foreign manufacturers also need reliable inventory and distribution records to support these responsibilities.

This makes local warehousing and fulfillment part of regulatory execution rather than purely logistics.

Build Indonesia Market Entry Around the Entire Supply Chain

Medical device market entry works best when manufacturers connect regulatory strategy with the physical supply chain.

The process should begin before the first Indonesian purchase order.

Foreign manufacturers should first confirm the device classification and intended market positioning.

(ALSO READ: Import Makanan dari China 2026: 7 Produk yang Punya Peluang Besar untuk Dijual di Indonesia)

They should then identify the documentation needed from the manufacturing facility.

Companies sourcing from China should verify whether the supplier can provide the required quality and technical evidence.

Factory audits can help confirm actual manufacturing capabilities.

Quality control can verify whether mass production remains consistent with approved specifications.

These sourcing controls matter because registration documents describe a specific product configuration.

Uncontrolled manufacturing changes can create differences between registered specifications and commercially supplied products.

After sourcing readiness, the company should establish its Indonesian representation and registration pathway.

The local operation must then prepare for importation, storage, distribution, and post-market responsibilities.

AsiaCommerce connects these stages through three core cross-border services.

First, we support sourcing from China through supplier negotiation, factory audits, and quality control.

Second, we support expansion into Indonesia, Malaysia, and the Philippines through compliance and market-entry coordination.

Third, we support e-commerce and local distribution through warehousing, marketplace fulfillment, and operational infrastructure.

Medical device requirements differ across Southeast Asian markets.

Approval in Indonesia does not automatically provide authorization in Malaysia or the Philippines.

Regional manufacturers should therefore build separate regulatory strategies for each destination.

The supply chain should support those strategies before manufacturers scale production.

This approach helps businesses avoid separating regulatory approval from sourcing and commercial execution.

If your device is ready for Southeast Asia but your local registration and distribution structure are not, market-entry coordination is usually the real gap.

📲 Consult your Indonesia medical device market entry strategy now via WhatsApp: +62 877-7704-7097 (*)

AsiaCommerce: Cross-Border Supply Chain Enabler for Southeast Asia